首页> 美国卫生研究院文献>Cytotechnology >Isolation of osteoprogenitors from murine bone marrow by selection of CD11b negative cells
【2h】

Isolation of osteoprogenitors from murine bone marrow by selection of CD11b negative cells

机译:通过选择CD11b阴性细胞从鼠骨髓中分离骨祖细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Selection of cells having the most osteogenic potential is a strategy used in bone tissue engineering. Preclinical studies using murine bone marrow cells must consider the large amount of hematopoietic cells in the adherent fraction. The aim of this study was to enrich a murine bone marrow cell population with osteoprogenitors by using a simple and reliable method. Bone marrow from C57Bl/6 mice was extracted and cells which adhered onto plastic were expanded in primary culture for 14 days. Immunolabeling of the CD11b surface antigen was performed and the CD11b cell fraction was isolated by FACS. Sorted and unsorted populations were analyzed for gene expression of osteoblast differentiation, alkaline phosphatase (AlkP) activity and matrix mineralization capacities. Selection of CD11b cells increased the number of AlkP+ cells from the plastic adherent fraction from 6.3% ± 0.8 to 56% ± 3.3 with a sevenfold increase in AlkP activity. mRNA analysis revealed a significant increase in the CD11b fraction for Osterix (41-fold), RANKL (17-fold), M-CSF (8-fold) and Runx-2 (8-fold). An osteogenic population was obtained with improved capacities to produce a mineralized extracellular matrix in vitro, independently of the presence of glucocorticoids in the culture medium.
机译:具有最大成骨潜能的细胞的选择是在骨组织工程中使用的策略。使用鼠类骨髓细胞的临床前研究必须考虑粘附部分中的大量造血细胞。这项研究的目的是通过使用一种简单可靠的方法,用骨祖细胞富集鼠骨髓细胞群。提取C57Bl / 6小鼠的骨髓,将附着在塑料上的细胞在原代培养中扩增14天。进行CD11b表面抗原的免疫标记,并通过FACS分离CD11b -细胞级分。分析了分类和未分类的种群的成骨细胞分化基因表达,碱性磷酸酶(AlkP)活性和基质矿化能力。选择CD11b -细胞可使塑料粘附分数中的AlkP + 细胞数量从6.3%±0.8增至56%±3.3,AlkP活性增加了七倍。 mRNA分析显示,Osterix(41倍),RANKL(17倍),M-CSF(8倍)和Runx-2(8倍)的CD11b -分数显着增加。 。获得的成骨细胞具有提高的能力,可在体外产生矿化的细胞外基质,而与培养基中糖皮质激素的存在无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号